ASH 2019 | Relapsed myeloma reports: CAR-T, bispecific Abs & combinations

Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, shares his overview of the latest updates for multiple myeloma (MM) in the relapsed setting from the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL. Prof. Mohty specifically discusses CAR-T, bispecific antibodies and new combination regimens.